• Home
  • Study Details

YouTHrive - Connecting youth and young adults to optimize ART adherence

The purpose of this research study is to learn how technology can be used to support young people living with HIV. Participants in this study will get access to online information, activities, and resources related to their health and well-being, as well as common problems that young people living with HIV face.

Age & Gender

  • 15 years ~ 24 years
  • Male, Female, Gender Inclusive


What will be asked of you

At each visit, we'll ask participants to fill out surveys, provide a urine sample, and provide a blood sample either in person or remotely. Participants will also be asked to fill out an online survey and participate in an online interview.


up to $170 for completing all study activities. Contact the study team for more information.

Total length of participation : 11 months

Looking for Specific Volunteers

Able to participate:

  • Are HIV-positive
  • Have a current ART prescription
  • Forget to take their ART medication and/or have missed HIV care appointments
  • Able to travel to UNC-Chapel Hill campus for multiple visits
  • Have reliable internet and text messaging access.

Not eligible if:

  • Are enrolled in another ART-related research study
  • Are a member of an iTech Youth Advisory Board
  • You participated in a previous focus group about this study

Contact the Team

Visit Location

100% Remote (online, phone, text)

Additional Study Information

Principal Investigator

Lisa Hightow-Weidman
Medicine-Infectious Diseases

Study Type

Behavioral or Social

Study Topics

Child and Teen Health
Men's Health

IRB Number




logo for the North Carolina Translational and Clinical Sciences Institute
logo for UNC Health
logo for UNC School of Medicine
logo for UNC Research
Research for Me logo

Copyright © 2013-2020 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH.  This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.


  • This email address is being protected from spambots. You need JavaScript enabled to view it.